The scent of potential change is in the air, and it’s not just the latest batch of Gelato. In hushed conversations at industry conferences and optimistic forecasts from Wall Street analysts, a surprising narrative is taking root: the cannabis industry is quietly, cautiously, preparing for the possibility of meaningful federal reform under a second Trump administration. This isn’t about partisan cheerleading; it’s a cold, hard analysis of shifting political winds, evolving campaign rhetoric, and a stark recognition that the status quo of federal prohibition is a crumbling dam. Let’s unpack why the mood is shifting from dread to strategic optimism regarding Trump cannabis policy in 2026.
From Skepticism to Strategic Hope
Let’s be blunt: the industry’s memory is long. The first Trump term was marked by Attorney General Jeff Sessions’ attempted crackdown, rescinding the Cole Memo that provided a tenuous shield for state-legal programs. The fear was real. Yet, fast forward to the 2024 campaign trail and the tone shifted palpably. Trump began framing cannabis as a “states’ rights” issue, a core conservative principle. He criticized the Biden administration’s slow pace on rescheduling and, in a pivotal moment, stated he would “absolutely” consider decriminalizing or rescheduling cannabis at the federal level if re-elected.
This wasn’t happening in a vacuum. As of March 2026, 42 states have legalized medical cannabis, and 24 plus D.C. have legalized adult use. The map is overwhelmingly green. The political calculus for any candidate, especially one eyeing a broad coalition, has irrevocably changed. Opposing a popular, job-creating industry that polls near 70% national support is simply bad politics.
The Political Calculus of a Green America
So, what’s the play? Insiders and lobbyists I speak with point to a few key factors that make Trump’s cannabis policy in a potential second term look different.
The Banking Bill as a Likely First Step
The most probable bipartisan victory is the SAFER Banking Act. This legislation, which has passed the House multiple times, would grant state-legal cannabis businesses access to essential financial services. For a Trump administration, this is a low-hanging, pro-business win. It doesn’t full-throatedly endorse legalization; it simply acknowledges the reality of a $40+ billion industry operating in cash. Signing it would be framed as supporting small businesses and public safety—a narrative that fits neatly into a conservative agenda.
Rescheduling vs. Descheduling: The Administrative Path
The Biden administration’s move to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act was historic, but it left the industry wanting more. Schedule III still imposes significant tax burdens (via IRS code 280E) and maintains federal criminalization for non-medical use. A Trump administration could let that rescheduling proceed, taking credit for a deregulatory move initiated under his predecessor. More optimistically, some believe a proactive Trump DOJ and DEA could be pushed to consider descheduling—removing cannabis from the CSA entirely—though this is seen as a longer shot.
A States' Rights Framework as the Ultimate Compromise
This is the core of the industry’s hope. A federalist approach, where the federal government officially cedes authority to the states, is the cleanest political solution for a Republican administration. It would involve passing legislation that protects state-legal programs and allows interstate commerce for those states that opt in, while allowing prohibitionist states to maintain their bans. It ends the federal-state conflict without forcing a national “legalization” stamp. For legacy operators in places like California or Colorado, and new markets like Ohio and Florida (should its adult-use amendment pass), this would be a game-changer, finally allowing operations like North Atlantic Seed Company to serve the national market without fear.
The Risks and Remaining Red Flags
The optimism is cautious for a reason. The industry is not wearing rose-colored glasses. A libertarian-leaning Trump could be swayed by advisors with more prohibitionist views. Any reform could come with hefty regulatory burdens or favor large, donor-friendly conglomerates over the small craft growers who built this culture. And let’s not forget the core base: while support is growing, some segments remain firmly opposed, creating a potential political backlash.
Furthermore, the industry’s diversity and social equity goals may not align with the priorities of a Trump administration. The hard work of repairing the harms of the War on Drugs could be sidelined in favor of a purely economic, free-market rollout.
What This Means For You
Whether you’re a consumer, a homegrower, or an aspiring entrepreneur, this shifting political landscape matters. Federal rescheduling or descheduling would trigger massive institutional investment, likely leading to lower prices, more product innovation, and broader availability—but also potentially more corporate consolidation. For the craft enthusiast, protecting the legacy of unique genetics like Original Glue will become more important than ever.
For now, the message is to stay informed and engaged. The next 12-24 months could see the most significant federal policy shift in cannabis history. Support advocacy groups that align with your values, from social justice to small business protection. The industry’s cautious optimism is a signal that change is possible, but the final shape of that change is still up for grabs. The future isn’t just being written in Washington; it’s being demanded by voters in every state that has gone green. And that’s a political force no administration, Trump 2.0 or otherwise, can easily ignore.
